Thymocytotoxic antibodies in synovial fluid

Area of Science:

• Immunology
• Rheumatology
• Cell Biology

Background:

• Thymocytotoxic activity, previously found in human serum, is mediated by IgM antibodies and complement.
• Synovial fluid (SF) is a key site for immune processes in joint diseases.

Purpose of the Study:

• To investigate the presence and characteristics of thymocytotoxic activity in synovial fluid from patients with various joint conditions.
• To compare SF thymocytotoxic activity with that found in serum and explore its potential role in joint pathology.

Main Methods:

• Synovial fluid samples from patients with juvenile rheumatoid arthritis (JRA), osteochondritis, traumatic synovitis, and septic arthritis were analyzed.
• Thymocytotoxic activity was assessed using guinea pig thymocytes.
• IgM was depleted using anti-IgM antibody-coated protein A-Sepharose, and heat inactivation (56°C for 30 min) was used to assess complement involvement.

Main Results:

• Thymocytotoxic activity was detected in all tested synovial fluid samples.
• The activity was abolished by IgM depletion or heat inactivation, and restored upon recombination, indicating mediation by IgM and a heat-labile factor (likely complement).
• The activity in SF was similar to serum, though generally lower in IgM levels and cytotoxic potency, with higher activity noted in some JRA patients.

Conclusions:

• Synovial fluid contains IgM-associated thymocytotoxic activity identical to that found in serum.
• This activity may play a role in local immune regulation within the joint, particularly in conditions like juvenile rheumatoid arthritis.